Don't Know Much About Health Care and Public Health: Politicans' and Pundits' Unjustified Statements About Causation, Benefits and Risks

Source: Health Care Renewal - Category: Health Management Tags: ill-informed management logical fallacies public health vaccines Source Type: blogs

Related Links:

Our country is facing a national health crisis on a scale that has never been seen before in our lifetimes. The COVID-19 pandemic is unchartered territory —a new strain of an old virus that has so far claimed more than 1,000 lives. Right now, we are all nervous for what’s still to come—not just for ourselves, […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Conditions COVID-19 coronavirus Infectious Disease Source Type: blogs
RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major adverse limb and cardiovascular (CV) events by 15 percent in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization, with similar rates of TIMI[1] major bleeding. VOYAGER PAD is the only study to show a significant benefit...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Human trials will begin imminently – but even if they go well, there are many hurdles before global immunisation is feasibleCoronavirus – latest updatesSee all our coronavirus coverageEven at their most effective – and draconian – containment strategies have only slowed the spread of the respiratory disease Covid-19. With the World Health Organization finally declaring a pandemic, all eyes have turned to the prospect of a vaccine, because only a vaccine can prevent people from getting sick.About 35 companies and academic institutions are racing to create such a vaccine, at least four of which alread...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Infectious diseases Vaccines and immunisation Medical research Microbiology Science World news Health Society Source Type: news
Authors: Insamran W, Sangrajrang S Abstract Since 2000 cancer has been the leading cause of death in Thailand. In response to this challenge, the National Cancer Institute of Thailand (NCI), in collaboration with other bodies, has developed and promoted the National Cancer Control Program (NCCP) to provide appropriate policies and practice for the prevention, early detection and treatment of cancer, with optimal supportive care. With plans strongly supported by the Ministry of Public Health, the NCCP envisages integration into the health care system in 6 strategic areas: (1) cancer informatics; (2) primary preventi...
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
No abstract available
Source: RETINA - Category: Opthalmology Tags: Editorial Source Type: research
To prepare for annual flu seasons, as well as possible pandemics, the US government has invested tens -- if not hundreds -- of millions of dollars over the past 15 years to ensure there are enough eggs for vaccines.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news
Ryan BourneHuman life is highly valuable. Basic economic reasoning therefore suggests that, given the risks of COVID-19 to vulnerable populations, we should be willing to withstand large economic costs to prevent the risk of substantial numbers of deaths. This is particularly true if most of those economic costs are temporary.In response to Donald Trump ’stweet last week suggesting “WE CANNOT LET THE CURE BE WORSE THAN THE PROBLEM ITSELF,”many economists have indeed been makingthese points.They highlight estimates suggesting that the estimated value of a statistical life (commonly around $9.3 million...
Source: Cato-at-liberty - Category: American Health Authors: Source Type: blogs
As new cases appear in the U.S., some — including the president — have compared it to the seasonal flu. Here’s a close look at the differences.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Quarantines Influenza Ventilators (Medical) Deaths (Fatalities) Tests (Medical) Epidemics Vaccination and Immunization SARS (Severe Acute Respiratory Syndrome) United States Politics and Government Pneumonia F Source Type: news
Around the world, more than 40 teams are working on a vaccine for Covid-19. We followed one doctor in the most urgent quest of his life. By Samanth SubramanianCoronavirus – latest updatesSee all our coronavirus coverageOf the dozens of places where a coronavirus vaccine might be born, one is DIOSynVax, a small company started by a Canadian pathologist named Jonathan Heeney. In ordinary times, I ’d have visited Heeney in his office, in a stately red-brick building in Cambridge. I’d have met his team and his Aria III cytometer, which looks like as if might brew a strong, space-age espresso but which, in fac...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Vaccines and immunisation Infectious diseases Medical research Microbiology Science World news Health Source Type: news
More News: Health Management | International Medicine & Public Health | Politics | Vaccines